<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02158000</url>
  </required_header>
  <id_info>
    <org_study_id>khalid-ahmed 5</org_study_id>
    <nct_id>NCT02158000</nct_id>
  </id_info>
  <brief_title>Aspiration of Excessive Endometrial Fluid at the Day of Ovum Retrieval Plus Diosmin in (ICSI) Cycles</brief_title>
  <official_title>Aspiration of Excessive Endometrial Fluid at the Day of Ovum Retrieval Plus Diosmin in (ICSI) Cycles</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Benha University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Benha University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To notify the effect of aspiration of excessive endometrial fluid in addition to Diosmin in
      cases undergoing intracytoplasmic sperm injection (ICSI) cycles.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Objectives: To notify the effect of aspiration of excessive endometrial fluid in addition to
      Diosmin in cases undergoing intracytoplasmic sperm injection (ICSI) cycles.

      Study design: Prospective randomized controlled clinical trial.

      Patients and Methods: 200 women with excessive endometrial fluid by transvaginal ultrasound
      during ICSI cycles are randomly scheduled into two equal groups. In group A, one tab every 8
      hs Diosmin ( 500mg) beginning from the day of ovum retrieval in addition to aspiration of the
      fluid by an IUI catheter ; while in group B (control group), no thing is given or done. The
      main outcome measures are presence of the fluid on the day of embryo transfer and the
      pregnancy rate on those patients.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 2013</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">November 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>the pregnancy rate</measure>
    <time_frame>is checked 16 days after embryos transfer</time_frame>
    <description>is assessed by :serum hCG test Beta sub-unit of hCG (serum hCG test)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>presence of the fluid on the day of embryo transfer</measure>
    <time_frame>at the day of embryo transfer</time_frame>
    <description>detection of excessive endometrial fluid by transvaginal ultrasound during ICSI cycles</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Infertility</condition>
  <arm_group>
    <arm_group_label>Group A</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>In group A , 100 women with excessive endometrial fluid by transvaginal ultrasound during ICSI cycles are allocated to receive one tab / 8 hs of Diosmin ( 500mg) beginning from the day of ovum retrieval and for 3 days (till the day of embro trasfer) in addition to aspiration of the fluid by an IUI catheter.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group B</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>In group B (control group) 100 women with excessive endometrial fluid by transvaginal ultrasound during ICSI cycles, no thing will be done</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>group A</intervention_name>
    <description>one tab every 8 hs Diosmin ( 500mg) beginning from the day of ovum retrieval in addition to aspiration of the fluid by an IUI catheter</description>
    <arm_group_label>Group A</arm_group_label>
    <other_name>Daflon</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  women with excessive endometrial fluid by transvaginal ultrasound during ICSI cycles

        Exclusion Criteria:

          -  none
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>23 Years</minimum_age>
    <maximum_age>48 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>khalid mohamed</last_name>
    <role>Study Chair</role>
    <affiliation>Department of Obstetrics and Gynecology, Benha University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>khalid mohamed</last_name>
    <phone>201281469651</phone>
    <email>dr.khalidkhader77@yahoo.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Benha univesity hospital</name>
      <address>
        <city>BanhƒÅ</city>
        <state>El Qualyobia</state>
        <zip>13518</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>khalid mohamed, MD</last_name>
      <phone>+2001281469651</phone>
      <email>dr.khalidkhader77@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>ahmed saad, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>June 5, 2014</study_first_submitted>
  <study_first_submitted_qc>June 5, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 6, 2014</study_first_posted>
  <last_update_submitted>March 9, 2020</last_update_submitted>
  <last_update_submitted_qc>March 9, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 10, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Benha University</investigator_affiliation>
    <investigator_full_name>khalid abd aziz mohamed</investigator_full_name>
    <investigator_title>lecturer of ob/gyn</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>on research gate</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

